Your session is about to expire
← Back to Search
COVID Prevention Counseling and Text Messaging for COVID-19
Study Summary
This trial will look at how well tailored counseling and text messaging can help reduce COVID-19 spread after diagnosis. Patients are randomly assigned to one of two groups, with one receiving extra support.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 or older and a patient at a federally qualified health center.I do not have a cognitive condition like schizophrenia or Down syndrome that would prevent me from following counseling.
- Group 1: Enhanced Standard-of-Care
- Group 2: Standard-of-Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there currently any recruitment opportunities for this research project?
"According to the clinicaltrials.gov database, this medical trial is actively accepting participants as of January 20th, 2023. The study was initially posted on April 11th 2022 and has since been revised multiple times."
What is the total sample size for this research project?
"Correct. According to the data published on clinicaltrials.gov, this medical trial launched on April 11th 2022 is actively looking for participants. 256 individuals are required from a single location, and the information was last updated January 20th 2023."
Share this study with friends
Copy Link
Messenger